IPO News Archive
Solazyme prices upsized IPO at $18, above the range
Solazyme, which transforms plant-based sugars into petroleum-based chemicals and fuels, raised $198 million by offering 10.975 million shares at $18, above the range of $15 to $17. The company had originally planned to offer 9.975 million shares, with the upside coming from additional primary shares; in total, the company raised 24% more than originally planned. Solazyme plans to list on the NASDAQ under the symbol SZYM. Morgan Stanley and Goldman, Sachs & Co. acted as lead managers on the deal.